Free Trial

BioRestorative Therapies (BRTX) Insider Trading & Ownership

BioRestorative Therapies logo
$1.54 +0.02 (+1.32%)
(As of 12/24/2024 05:19 PM ET)

BioRestorative Therapies (NASDAQ:BRTX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
25.50%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$165,751.52
Number Of
Insiders Selling
(Last 12 Months)
0
Get BRTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling BioRestorative Therapies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

BRTX Insider Buying and Selling by Quarter

BioRestorative Therapies Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/8/2024Francisco SilvaVPBuy1,708$1.16$1,981.28  
2/9/2024Dale BroadrickMajor ShareholderBuy86,041$1.32$113,574.12  
2/7/2024Dale BroadrickMajor ShareholderBuy36,374$1.38$50,196.12  
(Data available from 1/1/2013 forward)

BRTX Insider Trading Activity - Frequently Asked Questions

The list of insiders at BioRestorative Therapies includes Dale Broadrick, Francisco Silva, and Lance Alstodt. Learn more on insiders at BRTX.

25.50% of BioRestorative Therapies stock is owned by insiders. Learn more on BRTX's insider holdings.

The following insiders have purchased BRTX shares in the last 24 months: Dale Broadrick ($182,425.24), Francisco Silva ($12,979.16), and Lance Alstodt ($10,622.52).

Insiders have purchased a total of 146,464 BRTX shares in the last 24 months for a total of $206,026.92 bought.

The following insider sold BRTX shares in the last 24 months: Dale Broadrick ($995.42).

Insiders have sold a total of 528 BioRestorative Therapies shares in the last 24 months for a total of $995.42 sold.

BioRestorative Therapies Key Executives

  • Mr. Lance Alstodt (Age 53)
    Chairman of the Board, President & CEO
    Compensation: $954.17k
  • Mr. Robert Eugene Kristal (Age 56)
    Chief Financial Officer
    Compensation: $368.12k
  • Mr. Francisco J. Silva (Age 49)
    Chief Scientist, VP of Research & Development, Secretary and Director
    Compensation: $891.67k
  • Mr. Robert Paccasassi (Age 55)
    Vice President of Quality Assurance & Regulatory Compliance
    Compensation: $233.95k
  • Dr. Wayne J. Olan M.D.
    Clinical Director of Regenerative Disc & Spine Program and Member of Scientific Advisory Board


This page (NASDAQ:BRTX) was last updated on 12/25/2024 by MarketBeat.com Staff
From Our Partners